Literature DB >> 1939238

Mitosis-specific phosphorylation of myosin light chain kinase.

H Hosoya1, S Yamashiro, F Matsumura.   

Abstract

Cell cytosol preparations from mitotic HeLa cells exhibit a kinase activity that phosphorylates myosin light chain kinase (MLCK). This MLCK kinase activity is apparently distinct from the known MLCK kinases, including cAMP-dependent protein kinase, cGMP-dependent protein kinase, Ca(2+)-activated phospholipid-dependent protein kinase, or Ca(2+)-calmodulin-dependent protein kinase II, based on the following criteria. First, the MLCK kinase activity of mitotic cells does not respond to a variety of characteristic activators or inhibitors of these known kinases. Second, one- and two-dimensional peptide maps have revealed that the site of phosphorylation by the MLCK kinase of mitotic cells differs from those by these known kinases. The mitotic MLCK kinase phosphorylates MLCK at a threonine residue at a ratio of up to 1 mol of phosphate/mol of chicken gizzard MLCK. The MLCK kinase is mitosis-specific because mitotic cell extracts show much higher phosphorylation activity than nonmitotic cell extracts.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1939238

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  4 in total

1.  Plk is an M-phase-specific protein kinase and interacts with a kinesin-like protein, CHO1/MKLP-1.

Authors:  K S Lee; Y L Yuan; R Kuriyama; R L Erikson
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

2.  Dephosphorylation of cdc2 on threonine 161 is required for cdc2 kinase inactivation and normal anaphase.

Authors:  T Lorca; J C Labbé; A Devault; D Fesquet; J P Capony; J C Cavadore; F Le Bouffant; M Dorée
Journal:  EMBO J       Date:  1992-07       Impact factor: 11.598

3.  Localization and activity of myosin light chain kinase isoforms during the cell cycle.

Authors:  A Poperechnaya; O Varlamova; P J Lin; J T Stull; A R Bresnick
Journal:  J Cell Biol       Date:  2000-10-30       Impact factor: 10.539

4.  Three-dimensional reconstruction of caldesmon-containing smooth muscle thin filaments.

Authors:  P Vibert; R Craig; W Lehman
Journal:  J Cell Biol       Date:  1993-10       Impact factor: 10.539

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.